{
    "Trade/Device Name(s)": [
        "Stratus\u00ae CS Acute Care\u2122 CardioPhase\u00ae hsCRP TestPak",
        "Stratus\u00ae CS Acute Care\u2122 CardioPhase\u00ae hsCRP CalPak",
        "Stratus\u00ae CS Acute Care\u2122 CardioPhase\u00ae hsCRP DilPak"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K060369",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033908"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD",
        "JIT"
    ],
    "Summary Letter Date": "February 10, 2006",
    "Summary Letter Received Date": "February 13, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5270",
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "C-reactive protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Stratus\u00ae CS analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Radial Partition Immunoassay (RPIA)",
        "Two-site sandwich assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for Stratus CS Acute Care CardioPhase hsCRP TestPak, CalPak, and DilPak for high-sensitivity CRP testing on Stratus CS analyzer using RPIA technology.",
    "Indications for Use Summary": "Quantitative determination of C-reactive protein in lithium and sodium heparin plasma as a marker for infection, tissue injury, inflammation, and as an independent risk/prognostic marker for cardiovascular disease and events.",
    "fda_folder": "Immunology"
}